Investment in Canada’s domestic pharmaceutical infrastructure is essential to ensure that the country has a “secure and consistent supply of prescription medicines,” the Canadian Generic Pharmaceutical Association has urged. The call comes as part of a “blueprint” document published by the body that also insists that an enhanced international role is needed for Canada, as well as engagement with manufacturers to create a local stockpile of essential drugs.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?